The peripheral T-cell lymphomas (PTCL) are relatively rare, heterogeneous, and
therapeutically challenging. While significant therapeutic gains and improved understanding …

Simple Summary T-cell lymphomas are a rare, heterogeneous family of lymphomas derived
from post-thymic T lymphocytes. For patients with relapsed or refractory disease, outcomes …

Over the past 30 years, the scientific community has made little progress in changing the
natural history of peripheral T-cell lymphomas. Of the haematological malignancies, T-cell …

The use of post-transplantation cyclophosphamide (PTCy) for graft-versus host-disease
(GVHD) prophylaxis has revolutionized allogeneic blood or marrow transplantation …

Background Cutaneous peripheral T‐cell lymphoma, not otherwise specified (PTL NOS) is
an aggressive, but poorly characterized neoplasm. Objectives The European Organization …

Whole-genome sequencing reveals potent therapeutic strategy for monomorphic
epitheliotropic intestinal T-cell lymphoma | Blood Advances | American Society of …

While the peripheral T-cell lymphomas (PTCL) remain a therapeutic challenge, and
increasingly account for a disproportionate number of lymphoma-related deaths, improved …

COI notes: Kalac, Matko-Janssen: Research Funding; Seagen, Acrotech Biopharma,
Cardinal Health, Guidepoint, GLG: Consulting Jain, Salvia-No relevant COI Tam …

Despite the remarkable improvements in the treatment and outcome of patients with
aggressive B-cell lymphoma, the peripheral T-cell lymphomas (PTCL) continue to carry a …

Peripheral T-cell lymphoma (PTCL) is a heterogeneous group of aggressive neoplasms with
poor outcomes, commonly affecting older patients with comorbidities. This study aims to …